(Q37074131)

18 August 2017

1 reference

title

Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer (English)

1 reference

18 August 2017

1 reference

1 reference

George R Simon

1

1 reference

18 August 2017

Mubeena Begum

series ordinal

2

1 reference

18 August 2017

Gerold Bepler

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

1

1 reference

18 August 2017

51-59

1 reference

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer

18 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.51

21 January 2018

Identifiers

DOI

10.2217/14796694.4.1.51

1 reference

18 August 2017

1 reference